Cite
Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL
MLA
Gonzalo Martínez-Fernández, et al. “Comparison in Safety of Chemotherapy Protocols for Blood Cancers: Toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.” Ecancermedicalscience, vol. 15, Mar. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9dc68eeb70f203e2a951be1714359c39&authtype=sso&custid=ns315887.
APA
Gonzalo Martínez-Fernández, Jesús Lorenzo Algarra, Mari Carmen Montoya-Morcillo, Irene Gómez-Catalán, Alberto Marín-Sánchez, Juan Ramón Romero-Macías, Francisco Hernández-Fernández, & Ángela Ibañez García. (2021). Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL. Ecancermedicalscience, 15.
Chicago
Gonzalo Martínez-Fernández, Jesús Lorenzo Algarra, Mari Carmen Montoya-Morcillo, Irene Gómez-Catalán, Alberto Marín-Sánchez, Juan Ramón Romero-Macías, Francisco Hernández-Fernández, and Ángela Ibañez García. 2021. “Comparison in Safety of Chemotherapy Protocols for Blood Cancers: Toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.” Ecancermedicalscience 15 (March). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9dc68eeb70f203e2a951be1714359c39&authtype=sso&custid=ns315887.